Immunomedics

About:

Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer.

Website: https://www.immunomedics.com

Twitter/X: ImmunomedicsInc

Top Investors: New Enterprise Associates

Description:

Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.

Total Funding Amount:

$802M

Headquarters Location:

Morris Plains, New Jersey, United States

Founded Date:

1982-07-01

Contact Email:

contact(AT)immunomedics.com

Founders:

David M. Goldenberg

Number of Employees:

101-250

Last Funding Date:

2019-12-04

IPO Status:

Delisted

© 2025 bioDAO.ai